Navigation Links
Top Tips for Choosing the Ideal UV Disinfection Device
Date:10/19/2013

MEMPHIS, Tenn., Oct. 18, 2013 /PRNewswire/ -- As the Association for Professionals in Infection Control and Epidemiology kicks off a new awareness campaign about health care-associated infections next week during International Infection Prevention Week, it's sure to rouse interest in the demand for preventive measures to rid hospitals of these dreaded and deadly HAIs. UV disinfection is among the measures leaders at top hospitals around the U.S. and Canada are considering when waging war on superbugs that threaten patients, physically and financially.

A recent report by MedERA, "Economic Burden of Healthcare-Associated Infections in U.S. Acute Care Hospitals -- Societal Perspective" published in the Journal of Medical Economics online edition, estimates that HAIs may cost both hospitals and patients combined up to $147 billion annually. An earlier report by the Centers for Disease Control and Prevention estimated that HAIs cost hospitals alone up to $33.8 billion per year. The staggering financial impact of HAIs is forcing infection preventionists to address the cost burden for both hospitals and affected patients.

While UV disinfection technology isn't new – the first and only "smart" device, TRU-D SmartUVC(TM), entered the market in 2007 – hospital executives are still trying to determine the best way to make an informed purchase. Armed with a list of top questions to consider, they can determine which device will help achieve necessary HAI reduction rates for their hospital or facility.

What to consider:

  • Is there evidence-based data from independent clinical research and third-party/peer-reviewed studies confirming the effectiveness of the device?
  • What hospitals are using this technology?
  • Is the device able to precisely measure variables including UV-C reflective properties, dose delivery and bulb degradation over time?
  • Does the disinfection cycle take place from a single location in the room or does it require movement to multiple places for complete terminal disinfection?
  • Does the device disinfect all surfaces, including shadowed areas?
  • How long has the device been on the market?

There isn't a large amount of research published on the many devices available in the marketplace, making the decision more challenging for some. Due to TRU-D's first-to-market status and its patented, intuitive Sensor360(TM) technology, it has been the device of choice for the vast majority of existing third-party research on UV disinfection in health care settings, including an ongoing $2 million study funded by the CDC's Epicenter Program taking place at Duke University and the University of North Carolina, among other hospitals.

For hospital leaders like Mario Soares, director of infection prevention and control at Houston Methodist Hospital, the addition of the TRU-D robot and its technology were in line with their commitment to patient safety.

"Increased evidence in scientific literature indicates that UV light disinfection technology has the power to sterilize entire rooms and render common hospital pathogens, such as influenza, norovirus and methicillin-resistant Staphylococcus aureus, harmless to patients," Soares said.

Early adopters of the technology are seeing great benefit from using TRU-D and have been able to document success, which has led to the purchase of additional devices for their facilities.

"We had isolated clusters of infection in our burn unit and ICU," said Terry Burger, director of infection control and prevention at Lehigh Valley Health Network. "Disinfecting the rooms with TRU-D halted both clusters."

Lehigh Valley now deploys a fleet of seven TRU-D robots to proactively disinfect patient areas, including patient rooms and surgery suites.

While purchase price is similar across the board, variables like maintenance costs, monthly fees and the overall quality of the product make a difference when selecting the right technology. Armed with the right questions, hospital leaders can make an informed decision about UV disinfection technology.

About TRU-D

More than 100 TRU-Ds have been deployed to disinfect hospitals across the U.S., Canada and Europe. For information and links to independent studies on TRU-D, visit www.TRU-D.com.

For more information, contact:
Lauren Hannaford
Obsidian Public Relations
Phone: 901-572-1042 
Email

Read more news from TRU-D.


'/>"/>
SOURCE TRU-D
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New National Survey Shows Majority of Americans Confident About Choosing Health Coverage
2. New Study Introduces Valuable Tool to Aid Doctors and Patients in Choosing Successful Outcomes for Cheek Rejuvenation
3. Consumers Choosing Organic Alternatives to Traditional Pharmaceuticals
4. May Is the Ideal Time to "Window Shop" for Hearing
5. Wacoms DTH-2242: An Ideal Interactive Pen and Touch Display Solution for Healthcare and Presentation Markets
6. Independa, IDEAL LIFE to Provide Plug-and-Play Health Monitoring for Independent Elderly and Their Caregivers
7. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
8. Hospital Acquired Infection Control Market: Sterilization, Disinfection, Testing and Treatment
9. Groundbreaking UK Study Confirms Significant Reduction in Hospital Superbug Pathogens with TRU-D SmartUVC Disinfection Robot
10. New Ozone-Based Disinfection Technology Eradicates MRSA From Infected Hospital Rooms - In Less Than 60 Minutes
11. Infection Control Market - Sterilization & Disinfection - Global forecast to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)...   The Accreditation Council for Medical Affairs ... the pharmaceutical industry has appointed Dr. Jane ... formed scientific advisory board. Dr. Chin will be ... ever medical affairs think tank within the pharmaceutical ... ACMA, please visit  www.medicalaffairsspecialist.org .  Connect with ...
(Date:3/24/2017)... DUBLIN , Mar. 24, 2017 Research and ... (IPF) Pipeline Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with ... Corporation, Merck & Co., Inc., Biogen and Sanofi are involved in the ... candidates, of which one is in Phase III stage, 15 are in ...
(Date:3/24/2017)... -- Today Stock-Callers.com have issued research reports on ... (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences Corp. (NYSE: ... These companies are part of the Healthcare sector, which gave ... rd , 2017, with the NYSE Health Care Index declining ... in the S&P 500 were down about 0.4% as a ...
Breaking Medicine Technology:
(Date:3/24/2017)... Calif. (PRWEB) , ... March 24, 2017 , ... ... raised over $100,000 for its innovative EcoQube Frame vertical micro-veggies garden on ... instant demand for the product – with nearly 2,000 consumers (and counting) already ...
(Date:3/24/2017)... , ... March 24, 2017 , ... Viewers who like ... of critical historical facts, cultural practices, goods, services, and societal issues tend to appreciate ... look into the popular practice of utilizing running events for causes around the world. ...
(Date:3/24/2017)... ... ... “End Time GPS”: a dauntless and enlightened study of the second-coming of ... creation of published author, Wesley Gerboth, a World War II veteran, with a highly-regarded ... at age ninety-one, he shares the Wisdom God bestowed upon him in this publication. ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... A recent ... for entry into teacher preparation programs. The NCTQ report suggests, based on a review ... requirements would significantly improve teacher quality in the U.S. It argues that this higher ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of ... connectivity are making a huge impact on businesses and individual consumers alike. Laboratories ... IoT will have a value anywhere from $4 trillion to $11 trillion dollars by ...
Breaking Medicine News(10 mins):